Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06748144 · ClinicalTrials.gov registry record · Phase 2
IO Vancomycin Spine
A Phase 2 study, sponsored by The Methodist Hospital Research Institute.
- Not yet
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT06748144 is a Phase 2 study that has not yet begun recruiting, run by The Methodist Hospital Research Institute. The registered enrollment target is 30 participants.
The verdict
NCT06748144, a Phase 2 study, has not yet begun recruiting, sponsored by The Methodist Hospital Research Institute.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this research is to learn if injecting the antibiotic vancomycin directly into the bone marrow (intraosseous) or IO) during a lumbar (spinal) fusion surgery, is as effective or better than the standard method of giving it vancomycin through a vein (intravenous) or IV) during lumbar fusion surgery.
Interventions
- DRUG Intravenous Vancomycin
- DRUG Intraosseous Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-05 |
| Est. Completion | 2030-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06748144
The ClinicalTrials.gov registry entry for NCT06748144 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intravenous Vancomycin is the first listed.
NCT06748144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06748144 about?
NCT06748144 is a clinical study titled "IO Vancomycin Spine". The goal of this research is to learn if injecting the antibiotic vancomycin directly into the bone marrow (intraosseous) or IO) during a lumbar (spinal) fusion surgery, is as effective or better than the standard method of giving it vancomycin through a vein (intravenous) or IV) during lumbar fusio...
What is the current status of trial NCT06748144?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2026-05. Estimated completion is 2030-04.
What interventions are being tested in trial NCT06748144?
The interventions under investigation include: Intravenous Vancomycin (DRUG), Intraosseous Vancomycin (DRUG).
Who is sponsoring clinical trial NCT06748144?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.